New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Breakaway breast cancer cells can travel to the brain: Scientists plot path in quest to block entry

Breakaway breast cancer cells can travel to the brain: Scientists plot path in quest to block entry

by Delthia Ricks , Medical XpressIn vitro characterization of in vivo / ex vivo-derived 4T1 metastatic cell lines. (A) Schematic representation of the procedure used to generate the 4T1-BM2 metastatic
Oncology December 22,2023
Breakaway breast cancer cells can travel to the brain: Scientists plot path in quest to block entry

Breakaway breast cancer cells can travel to the brain: Scientists plot path in quest to block entry

by Delthia Ricks , Medical XpressIn vitro characterization of in vivo / ex vivo-derived 4T1 metastatic cell lines. (A) Schematic representation of the procedure used to generate the 4T1-BM2 metastatic
Oncology December 22,2023
Investigational drugs block bone loss in mice receiving chemotherapy

Investigational drugs block bone loss in mice receiving chemotherapy

byWashington University School of MedicineRed and green lines represent new bone in this image of a normal mouse bone. Exposure to chemotherapy and radiation during cancer treatment leads to bon
Breakthroughs December 22,2023
Investigational drugs block bone loss in mice receiving chemotherapy

Investigational drugs block bone loss in mice receiving chemotherapy

byWashington University School of MedicineRed and green lines represent new bone in this image of a normal mouse bone. Exposure to chemotherapy and radiation during cancer treatment leads to bon
Breakthroughs December 22,2023
Cancer mortality continues steady decline, driven by progress against lung cancer

Cancer mortality continues steady decline, driven by progress against lung cancer

byAmerican Cancer SocietyTrends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population Credit: American Cancer SocietyTh
Oncology December 22,2023
Cancer mortality continues steady decline, driven by progress against lung cancer

Cancer mortality continues steady decline, driven by progress against lung cancer

byAmerican Cancer SocietyTrends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population Credit: American Cancer SocietyTh
Oncology December 22,2023
Incidence of early-onset gastric cancer increasing in the U.S.

Incidence of early-onset gastric cancer increasing in the U.S.

(HealthDay)—The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer, according to a
Oncology December 22,2023
Incidence of early-onset gastric cancer increasing in the U.S.

Incidence of early-onset gastric cancer increasing in the U.S.

(HealthDay)—The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer, according to a
Oncology December 22,2023
Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

byNYU Langone HealthMouse pancreatic tumor cells (red) produce the signaling protein IL-1β (green) to support cancer growth by suppressing the immune system. Credit: NYU Grossman School of Medic
Oncology December 22,2023
Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

byNYU Langone HealthMouse pancreatic tumor cells (red) produce the signaling protein IL-1β (green) to support cancer growth by suppressing the immune system. Credit: NYU Grossman School of Medic
Oncology December 22,2023
Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

byMcGill UniversityCancer cell during cell division. Credit: National Institutes of HealthIt is known that the tumor microenvironment plays an important role in the progression of cancer. But co
Oncology December 22,2023
Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

byMcGill UniversityCancer cell during cell division. Credit: National Institutes of HealthIt is known that the tumor microenvironment plays an important role in the progression of cancer. But co
Oncology December 22,2023
Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr
Oncology December 22,2023
Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr
Oncology December 22,2023
Study shows lactate may prompt cancer formation

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate
Oncology December 22,2023
Study shows lactate may prompt cancer formation

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate
Oncology December 22,2023
Combining neurologic and blood pressure drugs reduces breast tumor development in mice

Combining neurologic and blood pressure drugs reduces breast tumor development in mice

byGeorgetown University Medical CenterCancer cell during cell division. Credit: National Institutes of HealthAdding a medication used to treat epilepsy, bipolar disorder and migraines to a blood
Oncology December 22,2023
Combining neurologic and blood pressure drugs reduces breast tumor development in mice

Combining neurologic and blood pressure drugs reduces breast tumor development in mice

byGeorgetown University Medical CenterCancer cell during cell division. Credit: National Institutes of HealthAdding a medication used to treat epilepsy, bipolar disorder and migraines to a blood
Oncology December 22,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com